INFLIXIMAB
infliximab 120 mg/mL injection, 1 mL pen device
INFLIXIMAB (13062L)
13062L
Manner of administration:Injection
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Initial treatment with the subcutaneous form where a concurrent PBS authority application
for the intravenously (IV) administered formulation is being made
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 2 | DPMQ: $578.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Remsima SC | |||||